One of neurologist Anelyssa D'Abreu's least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer's disease. But it's not quite as bad as it used to be. Today when they ask, "Is there anything we can do?" D'Abreu has a new answer: "Perhaps." Unlike a decade ago, when D'Abreu had little to offer her patients with Alzheimer's, there are now drugs that may impede the disease's progression.
Bob Milano, an Oakland kid who played catcher at Cal and then became the winningest baseball coach in school history, has died. He was 85. Milano retired following the 1999 season with 688 career victories. He was inducted to the Cal Athletics Hall of Fame in 2004 and had his jersey number 7 retired by the school. The school confirmed Milano's death on Monday afternoon.
We try to point out those bad papers because we still believe in science and want to make science better. But, I am very worried about how the work we do in pointing out bad papers is currently being misused, or even weaponized, to convince the general public that all science is bad.
There are differences in Alzheimer's patients and their gut microbiota, and that's been verified by many groups now. Prior research has shown that when you make changes in the gut microbiota of Alzheimer model mice, you in turn have effects on the pathology of the hallmarks of Alzheimer's - amyloid plaques and tau accumulation.